384 related articles for article (PubMed ID: 8863819)
1. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
[TBL] [Abstract][Full Text] [Related]
2. Potential of 5-HT-moduline as a drug target for affective disorders.
Fillion G
Curr Opin Investig Drugs; 2000 Sep; 1(1):104-9. PubMed ID: 11249585
[TBL] [Abstract][Full Text] [Related]
3. Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas.
Bonnin A; Grimaldi B; Fillion MP; Fillion G
Brain Res; 1999 Apr; 825(1-2):152-60. PubMed ID: 10216182
[TBL] [Abstract][Full Text] [Related]
4. Specific interaction of 5-HT-moduline with human 5-HT1b as well as 5-HT1d receptors expressed in transfected cultured cells.
Rousselle JC; Plantefol M; Fillion MP; Massot O; Pauwels PJ; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):279-86. PubMed ID: 9774213
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors.
Cloëz-Tayarani I; Cardona A; Rousselle JC; Massot O; Edelman L; Fillion G
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9899-904. PubMed ID: 9275223
[TBL] [Abstract][Full Text] [Related]
6. Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype.
Massot O; Rousselle JC; Grimaldi B; Cloëz-Tayarani I; Fillion MP; Plantefol M; Bonnin A; Prudhomme N; Fillion G
Ann N Y Acad Sci; 1998 Dec; 861():174-82. PubMed ID: 9928255
[TBL] [Abstract][Full Text] [Related]
7. [5HT-moduline an new peptide specifically interactive with the serotonergic system: physiopathologic implications].
Fillion G
Ann Pharm Fr; 1998; 56(4):145-7. PubMed ID: 9770005
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice.
Sarhan H; Grimaldi B; Hen R; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):12-8. PubMed ID: 10651141
[TBL] [Abstract][Full Text] [Related]
9. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
11. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
12. 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis.
Bentué-Ferrer D; Reymann JM; Rousselle JC; Massot O; Bourin M; Allain H; Fillion G
Eur J Pharmacol; 1998 Oct; 358(2):129-37. PubMed ID: 9808261
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
[TBL] [Abstract][Full Text] [Related]
14. The role and therapeutic potential of 5-HT-moduline in psychiatry.
Moret C; Grimaldi B; Massot O; Fillion G
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):137-46. PubMed ID: 12728412
[TBL] [Abstract][Full Text] [Related]
15. (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.
Davidson C; Ho M; Price GW; Jones BJ; Stamford JA
Br J Pharmacol; 1997 Jun; 121(4):737-42. PubMed ID: 9208142
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.
Brys R; Josson K; Castelli MP; Jurzak M; Lijnen P; Gommeren W; Leysen JE
Mol Pharmacol; 2000 Jun; 57(6):1132-41. PubMed ID: 10825383
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.
Marcoli M; Maura G; Munari C; Ruelle A; Raiteri M
Br J Pharmacol; 1999 Feb; 126(3):607-12. PubMed ID: 10188970
[TBL] [Abstract][Full Text] [Related]
18. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
[TBL] [Abstract][Full Text] [Related]
19. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
